MCID: CRN167
MIFTS: 19

Caronte

Aliases & Classifications for Caronte

MalaCards integrated aliases for Caronte:

Name: Caronte 58 56
Car 58

External Ids:

OMIM 58 604172

Summaries for Caronte

MalaCards based summary : Caronte, is also known as car. An important gene associated with Caronte is FGF8 (Fibroblast Growth Factor 8). Affiliated tissues include t cells, liver and b cells.

Wikipedia : 77 Caronte is the Italian name of Charon, the boatman of Hades, appearing in numerous versions of the... more...

Description from OMIM: 604172

Related Diseases for Caronte

Symptoms & Phenotypes for Caronte

Clinical features from OMIM:

604172

Drugs & Therapeutics for Caronte

Search Clinical Trials , NIH Clinical Center for Caronte

Genetic Tests for Caronte

Anatomical Context for Caronte

MalaCards organs/tissues related to Caronte:

42
T Cells, Liver, B Cells, Testes, Brain, Myeloid, Heart

Publications for Caronte

Articles related to Caronte:

(show top 50) (show all 2996)
# Title Authors Year
1
MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma. ( 30260046 )
2019
2
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma. ( 30121627 )
2019
3
Not so crystal clear: observations from a case of crystalline arthritis with cytokine release syndrome (CRS) after chimeric antigen receptor (CAR)-T cell therapy. ( 30291306 )
2019
4
CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products. ( 31019670 )
2019
5
Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell Therapy. ( 31056762 )
2019
6
Gluteal Burns from a Car Seat Heater in a Neurologically Intact Patient: A Case Report. ( 31023634 )
2019
7
Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL. ( 30846865 )
2019
8
Corrigendum to "Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models". ( 31032372 )
2019
9
3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids. ( 31036555 )
2019
10
Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients. ( 30962163 )
2019
11
CAR-Based Approaches to Cutaneous T-Cell Lymphoma. ( 31058076 )
2019
12
Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma. ( 30863720 )
2019
13
Safety of CAR T-Cell Therapy in Patients with B-Cell Lymphoma and Chronic Hepatitis B or C Virus Infection. ( 31101626 )
2019
14
Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma. ( 31078430 )
2019
15
Hypoxia Selectively Impairs CAR-T Cells In Vitro. ( 31052261 )
2019
16
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia. ( 31110217 )
2019
17
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T cell efficacy. ( 31076448 )
2019
18
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT). ( 31092900 )
2019
19
Delayed remission following sequential infusion of humanized CD19- and CD22-modified CAR-T cells in a patient with relapsed/refractory acute lymphoblastic leukemia and prior exposure to murine-derived CD19-directed CAR-T cells. ( 30988623 )
2019
20
CAR T Cell-Driven Trogocytosis Induces Antigen-Low Leukemia Relapse. ( 30979705 )
2019
21
Improving CAR T cell immunotherapy-mediated remissions for pediatric leukemia. ( 30985293 )
2019
22
Relapsed B-Acute Lymphoblastic Leukemia with Aberrant Myeloperoxidase Expression Following CAR T-cell Therapy: A Diagnostic Challenge. ( 30916805 )
2019
23
CD19 CAR T cell product and disease attributes predict leukemia remission durability. ( 30860496 )
2019
24
Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth. ( 30860598 )
2019
25
CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity. ( 30778134 )
2019
26
Fratricide-resistant CD1a-specific CAR T-cells for the treatment of cortical T-cell acute lymphoblastic leukemia. ( 30796021 )
2019
27
Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML). ( 30736352 )
2019
28
Current challenges for CAR T-cell therapy of acute myeloid leukemia. ( 30762880 )
2019
29
Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia. ( 30764841 )
2019
30
Allogeneic CAR T cell therapies for leukemia-R1. ( 30632623 )
2019
31
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia. ( 30391141 )
2019
32
CAR T cells mimicking an aggressive lymphoma. ( 30923108 )
2019
33
CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients. ( 30784033 )
2019
34
A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy. ( 30791947 )
2019
35
Anti-CD19 CAR T cell therapy for lymphoma - off to the races! ( 30814672 )
2019
36
Expansion deficiency of CAR-T cells in patients with lymphoma and resolution by T cell purification. ( 30834515 )
2019
37
The response to lymphodepletion impacts PFS in aggressive non-Hodgkin lymphoma patients treated with CD19 CAR-T cells. ( 30782611 )
2019
38
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice. ( 30622115 )
2019
39
Autophagy and apoptotic machinery caused by Polygonum cuspidatum extract in cisplatin‑resistant human oral cancer CAR cells. ( 30720102 )
2019
40
Fabrication of Bioactive Rifampicin loaded κ-Car-MA-INH/Nano Hydroxyapatite Composite for Tuberculosis Osteomyelitis Infected Tissue Regeneration. ( 31102805 )
2019
41
Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer. ( 30717444 )
2019
42
Evaluating object recognition ability in developmental prosopagnosia using the Cambridge Car Memory Test. ( 30973292 )
2019
43
Simulated car driving and its association with cognitive abilities in patients with schizophrenia. ( 30219605 )
2019
44
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies. ( 31091832 )
2019
45
Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus. ( 30842314 )
2019
46
Slamming the brakes on lupus with CAR T cells. ( 30952806 )
2019
47
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice. ( 30936321 )
2019
48
Targeting NR4As, a new strategy to fine-tune CAR-T cells against solid tumors. ( 30937188 )
2019
49
Solving the Single-Vehicle Self-Driving Car Trolley Problem Using Risk Theory and Vehicle Dynamics. ( 30937627 )
2019
50
Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL. ( 30938714 )
2019

Variations for Caronte

Expression for Caronte

Search GEO for disease gene expression data for Caronte.

Pathways for Caronte

GO Terms for Caronte

Sources for Caronte

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....